Mesalamine | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mesalamine
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Zhejiang Hengkang Mesalazine

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

Mesalamine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

91 API Suppliers, 53 USDMF, 34 CEP/COS, 13 JDMF, 14 EU WC, 10 KDMF, 45 NDC API, 41 Listed Suppliers, $ API Reference Price

91 API Suppliers
53 USDMF
34 CEP/COS
13 JDMF
14 EU WC
10 KDMF
45 NDC API
41 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

7 Intermediates Suppliers

7 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

442 FDF Dossiers, 41 FDA Orange Book, 293 Europe, 18 Canada, 40 Australia, 12 South Africa, 38 Listed Dossiers

442 FDF Dossiers
41 FDA Orange Book
293 Europe
18 Canada
40 Australia
12 South Africa
38 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

ENEMA;RECTAL - 4GM/60ML, CAPSULE, EXTENDED RELEASE;ORAL - 250MG, CAPSULE, EXTENDED RELEASE;ORAL - 500MG, CAPSULE, DELAYED RELEASE;ORAL - 400MG, SUPPOSITORY;RECTAL - 1GM, TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 1.2GM, CAPSULE, EXTENDED RELEASE;ORAL - 375MG

ENEMA;RECTAL - 4GM/60ML
CAPSULE, EXTENDED RELEASE;ORAL - 250MG
CAPSULE, EXTENDED RELEASE;ORAL - 500MG
CAPSULE, DELAYED RELEASE;ORAL - 400MG
SUPPOSITORY;RECTAL - 1GM
TABLET, DELAYED RELEASE;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - 1.2GM
CAPSULE, EXTENDED RELEASE;ORAL - 375MG

RELATED EXCIPIENT COMPANIES

8 Evonik, 3 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 11 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 31 BASF, 15 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Finar, 9 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 30 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 17 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 13 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

69 Coating Systems & Additives, 59 Fillers, Diluents & Binders, 44 Controlled & Modified Release, 37 Thickeners and Stabilizers, 31 Direct Compression, 28 Solubilizers, 28 Disintegrants & Superdisintegrants, 22 Granulation, 18 Lubricants & Glidants, 15 Topical, 15 Film Formers & Plasticizers, 13 Co-Processed Excipients, 11 Taste Masking, 9 Empty Capsules, 8 Rheology Modifiers, 7 Chewable & Orodispersible Aids, 6 Parenteral, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Surfactant & Foaming Agents

69 Coating Systems & Additives
59 Fillers, Diluents & Binders
44 Controlled & Modified Release
37 Thickeners and Stabilizers
31 Direct Compression
28 Solubilizers
28 Disintegrants & Superdisintegrants
22 Granulation
18 Lubricants & Glidants
15 Topical
15 Film Formers & Plasticizers
13 Co-Processed Excipients
11 Taste Masking
9 Empty Capsules
8 Rheology Modifiers
7 Chewable & Orodispersible Aids
6 Parenteral
5 API Stability Enhancers
4 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 66 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
66 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 200 Finished Drug Prices, 35 Annual Reports

9 US Medicaid Prescriptions
200 Finished Drug Prices
35 Annual Reports

MARKET PLACE

22 APIs, 14 FDF Dossiers

22 APIs
14 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 13 Health Canada Patents

4 US Patents
13 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 15 Others

4 EDQM
1 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 47 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1Y0000297

02 1Y0001563

03 1Y0001569

04 1Y0001574

filter CAS Number Reset all filters

4 All

01 1123-30-8

02 289-57-6

03 195-55-6

filter Reference Standard Reset all filters

4 All

01 1Mesalazine

02 1Mesalazine for system suitability

03 1Mesalazine impurity A

04 1Mesalazine impurity C

Axplora Mesalazine

Product Main Page

01

EDQM, Council of Europe

Mesalazine for system suitability

VMX

Not Confirmed

EDQM, Council of Europe

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Mesalazine for system suitability

CAS Number : 89-57-6

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001574

Batch No : 4

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Mesalazine impurity C

VMX

Not Confirmed

EDQM, Council of Europe

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Mesalazine impurity C

CAS Number : 95-55-6

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001569

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Mesalazine impurity A

VMX

Not Confirmed

EDQM, Council of Europe

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Mesalazine impurity A

CAS Number : 123-30-8

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001563

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Mesalazine

VMX

Not Confirmed

EDQM, Council of Europe

VMX

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CAS Number : 89-57-6

Quantity Per Vial : 50 mg

Sale Unit : 1

Order Code : Y0000297

Batch No : 3

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?